SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001513160-14-000058
Filing Date
2014-11-12
Accepted
2014-11-12 17:00:31
Documents
3
Period of Report
2014-11-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LION BIOTECHNOLOGIES, INC. CURRENT REPORT currentreport.htm 8-K 23865
2 PRESS RELEASE DATED NOVEMBER 12, 2014 ex991.htm EX-99.1 8288
3 LOGO lionlogo.jpg GRAPHIC 596544
  Complete submission text file 0001513160-14-000058.txt   855697
Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 141214857
SIC: 2836 Biological Products, (No Diagnostic Substances)